IV Glutathione 'Glow Drips' With Vitamin C: A 2026 Review Finds Too Little Evidence for Routine Use

Intravenous glutathione drips, often sold with vitamin C added, are marketed in many cities as a shortcut to lighter or brighter skin. A narrative review in the Journal of Medicine and Life, published in its July 2026 issue, looked at what the evidence actually shows for glutathione given by drip, by mouth and on the skin.

The authors, from the evercare clinic group in Riyadh and Shaqra University in Saudi Arabia, screened 431 records and included 40 studies. They did not pool the results, judging the studies too different from each other.

For the intravenous route they found only about two studies that directly measured skin lightening. One was an uncontrolled pilot in 21 adults in the Philippines. The other, a placebo-controlled trial in Pakistan, enrolled 50 people, of whom 32 finished; they received glutathione with vitamin C twice a week for six weeks, and about 37.5% reported improvement, judged largely by subjective assessment. That trial also recorded abnormal liver tests in eight patients and one case of anaphylaxis. The review lists further concerns from case reports and other settings, including a systemic inflammatory reaction, kidney and thyroid changes whose cause is unproven, and infection risks from repeated injections outside regulated clinics.

Vitamin C is a particular complication. It has its own effect on melanin production, so when it is infused with glutathione, nobody can tell which ingredient caused a change, or a side effect. The authors note that no adequately powered study has compared glutathione alone, vitamin C alone and the two together, and they call the rationale for combining them largely theoretical.

Oral and topical glutathione looked safer in the short term, but the trials were small and the lightening effect modest. The review cites regulator warnings from the Philippine FDA in 2019 and the Saudi FDA in 2015.

Its conclusion is that current evidence is too limited to justify routine cosmetic use of IV glutathione, and that it should be confined to closely supervised clinical or research settings. The authors disclosed no conflicts of interest.